Sentinel lymph node biopsy and melanoma: 2010 update Part I.

  title={Sentinel lymph node biopsy and melanoma: 2010 update Part I.},
  author={William G Stebbins and Lilit Garibyan and Arthur J. Sober},
  journal={Journal of the American Academy of Dermatology},
  volume={62 5},
  pages={723-34; quiz 735-6}
UNLABELLED Sentinel lymph node biopsy for melanoma was introduced in the early 1990s as a minimally invasive method of identifying and pathologically staging regional lymph node basins in patients with clinical stage I/II melanoma. Numerous large trials have demonstrated that sentinel lymph node evaluation has utility in improving accuracy of prognostication and for risk stratifying patients into appropriate groups for clinical trials. However, there remains a great deal of controversy… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 19 extracted citations


Publications referenced by this paper.
Showing 1-10 of 91 references

Sentinel lymph node biopsy in malignant melanoma

  • JM Thomas
  • BMJ
  • 2008
Highly Influential
8 Excerpts

Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: longterm follow-up results

  • RJ Vuylsteke, PA van Leeuwen, MG Statius Muller, HA Gietema, DR Kragt, S. Meijer
  • J Clin Oncol 2003;21:1057-65
  • 2003
Highly Influential
15 Excerpts

Similar Papers

Loading similar papers…